Based on the results of RNAseq, we hypothesized that ERK1/2 and TGFβ1/Smad3 signaling pathways, as well as apoptosis, were involved in inducing the protective effects of RRL against CS and LPS-induced COPD. The gene discussed is MAPK3; the disease is chronic obstructive pulmonary disease.